MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IONS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ionis Pharmaceuticals (IONS) Ownership - Who owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
1402
Web
https://www.ionis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.28B
P/E Ratio
N/A
Total Cash
2.05B
Projected Growth
N/A
Total Debt
1.61B
Revenue
874.09M
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
12.36
Total Debt/Equity
N/A
Revenue/Share
5.36 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
IONS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for IONS
A.I. Advisor
published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
1402
Web
https://www.ionis.com
Who owns Ionis Pharmaceuticals? IONS symbol Ownership - Tickeron.com